VistaGen Therapeutics, Inc. (VSTA) Vision for Stem Cell Technology Aligned with Broader Hopes for Cardiotoxicity
The U.S. pharmaceutical industry is facing a “drug discovery and development crisis,” says small-cap biotech VistaGen Therapeutics, evidenced by the…